Last 12 months
Inside the activity.
0 purchase rows · 35 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 16 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 17 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 04, 2011 Filed May 6, 2011 14:42 UTC |
Bowles Richard S IIIExe V-P & Chief Compl Officer
|
GrantRestricted Stock Unit · Derivative | 3,282 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-013359 · doc4.xml · derivative · entry 8 Bowles Richard S III · CIK 0001475384 · Exe V-P & Chief Compl Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,282 Underlying: Common Stock · 3,282 shares Expires 2014-05-04 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:42 UTC |
Bowles Richard S IIIExe V-P & Chief Compl Officer
|
SaleCommon Stock | 14,107 | $36.55 | $515,610.85 |
DisclosureSEC source: 0001225208-11-013359 · doc4.xml · nonDerivative · entry 5 Bowles Richard S III · CIK 0001475384 · Exe V-P & Chief Compl Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,575 Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:42 UTC |
Bowles Richard S IIIExe V-P & Chief Compl Officer
|
SaleCommon Stock | 13,300 | $36.56 | $486,248.00 |
DisclosureSEC source: 0001225208-11-013359 · doc4.xml · nonDerivative · entry 4 Bowles Richard S III · CIK 0001475384 · Exe V-P & Chief Compl Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,682 Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:42 UTC |
Bowles Richard S IIIExe V-P & Chief Compl Officer
|
SaleCommon Stock | 2,248 | $36.57 | $82,209.36 |
DisclosureSEC source: 0001225208-11-013359 · doc4.xml · nonDerivative · entry 3 Bowles Richard S III · CIK 0001475384 · Exe V-P & Chief Compl Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,982 Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:42 UTC |
Bowles Richard S IIIExe V-P & Chief Compl Officer
|
SaleCommon Stock | 100 | $36.56 | $3,655.50 |
DisclosureSEC source: 0001225208-11-013359 · doc4.xml · nonDerivative · entry 2 Bowles Richard S III · CIK 0001475384 · Exe V-P & Chief Compl Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,230 Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:42 UTC |
Bowles Richard S IIIExe V-P & Chief Compl Officer
|
Exercise / conversionCommon Stock | 29,755 | $22.69 | $675,140.95 |
DisclosureSEC source: 0001225208-11-013359 · doc4.xml · nonDerivative · entry 1 Bowles Richard S III · CIK 0001475384 · Exe V-P & Chief Compl Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,330 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:42 UTC |
Canan JohnSr.V-P Finc-Global Controller
|
GrantStock Option (right to buy) · Derivative | 44,776 | $0.00 Strike: $36.56 | $0.00 |
DisclosureSEC source: 0001225208-11-013360 · doc4.xml · derivative · entry 4 Canan John · CIK 0001374366 · Sr.V-P Finc-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,776 Underlying: Common Stock · 44,776 shares Expires 2021-05-03 F4 · derivative.exercise_date: The option vests in three equal annual installments beginning May 4, 2012. Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:42 UTC |
Canan JohnSr.V-P Finc-Global Controller
|
GrantRestricted Stock Unit · Derivative | 4,923 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-013360 · doc4.xml · derivative · entry 3 Canan John · CIK 0001374366 · Sr.V-P Finc-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,923 Underlying: Common Stock · 4,923 shares Expires 2014-05-04 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:42 UTC |
Deese Willie AExe V-P & Pres. MMD
|
GrantStock Option (right to buy) · Derivative | 104,478 | $0.00 Strike: $36.56 | $0.00 |
DisclosureSEC source: 0001225208-11-013361 · doc4.xml · derivative · entry 4 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,478 Underlying: Common Stock · 104,478 shares Expires 2021-05-03 F4 · derivative.exercise_date: The option vests in three equal annual installments beginning May 4, 2012. Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:42 UTC |
Deese Willie AExe V-P & Pres. MMD
|
GrantRestricted Stock Unit · Derivative | 7,659 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-013361 · doc4.xml · derivative · entry 3 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,659 Underlying: Common Stock · 7,659 shares Expires 2014-05-04 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:42 UTC |
FRAZIER KENNETH CDirector · President & CEO
|
GrantStock Option (right to buy) · Derivative | 559,701 | $0.00 Strike: $36.56 | $0.00 |
DisclosureSEC source: 0001225208-11-013362 · doc4.xml · derivative · entry 4 FRAZIER KENNETH C · CIK 0001181175 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 559,701 Underlying: Common Stock · 559,701 shares Expires 2021-05-03 F4 · derivative.exercise_date: The option vests in three equal annual installments beginning May 4, 2012. Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:42 UTC |
FRAZIER KENNETH CDirector · President & CEO
|
GrantRestricted Stock Unit · Derivative | 41,028 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-013362 · doc4.xml · derivative · entry 3 FRAZIER KENNETH C · CIK 0001181175 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,028 Underlying: Common Stock · 41,028 shares Expires 2014-05-04 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:43 UTC |
GRADDICK WEIR MIRIAN MExe V-P, HR
|
GrantStock Option (right to buy) · Derivative | 126,866 | $0.00 Strike: $36.56 | $0.00 |
DisclosureSEC source: 0001225208-11-013363 · doc4.xml · derivative · entry 3 GRADDICK WEIR MIRIAN M · CIK 0001168014 · Exe V-P, HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,866 Underlying: Common Stock · 126,866 shares Expires 2021-05-03 F3 · derivative.exercise_date: The option vests in three equal annual installments beginning May 4, 2012. Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:43 UTC |
GRADDICK WEIR MIRIAN MExe V-P, HR
|
GrantRestricted Stock Unit · Derivative | 9,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-013363 · doc4.xml · derivative · entry 2 GRADDICK WEIR MIRIAN M · CIK 0001168014 · Exe V-P, HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,300 Underlying: Common Stock · 9,300 shares Expires 2014-05-04 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:43 UTC |
Heller Bridgette PExe.VP & Pres.Con.Hlth.Care
|
GrantStock Option (right to buy) · Derivative | 74,627 | $0.00 Strike: $36.56 | $0.00 |
DisclosureSEC source: 0001225208-11-013364 · doc4.xml · derivative · entry 2 Heller Bridgette P · CIK 0001485616 · Exe.VP & Pres.Con.Hlth.Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,627 Underlying: Common Stock · 74,627 shares Expires 2021-05-03 F2 · derivative.exercise_date: The option vests in three equal annual installments beginning May 4, 2012. Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:43 UTC |
Heller Bridgette PExe.VP & Pres.Con.Hlth.Care
|
GrantRestricted Stock Unit · Derivative | 5,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-013364 · doc4.xml · derivative · entry 1 Heller Bridgette P · CIK 0001485616 · Exe.VP & Pres.Con.Hlth.Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,470 Underlying: Common Stock · 5,470 shares Expires 2014-05-04 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:43 UTC |
KELLOGG PETER NExe V-P & CFO
|
GrantStock Option (right to buy) · Derivative | 238,806 | $0.00 Strike: $36.56 | $0.00 |
DisclosureSEC source: 0001225208-11-013365 · doc4.xml · derivative · entry 3 KELLOGG PETER N · CIK 0001226287 · Exe V-P & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,806 Underlying: Common Stock · 238,806 shares Expires 2021-05-03 F3 · derivative.exercise_date: The option vests in three equal annual installments beginning May 4, 2012. Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:43 UTC |
KELLOGG PETER NExe V-P & CFO
|
GrantRestricted Stock Unit · Derivative | 17,505 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-013365 · doc4.xml · derivative · entry 2 KELLOGG PETER N · CIK 0001226287 · Exe V-P & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,505 Underlying: Common Stock · 17,505 shares Expires 2014-05-04 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:43 UTC |
KIM PETER SExe V-P & Pres, MRL
|
GrantStock Option (right to buy) · Derivative | 223,881 | $0.00 Strike: $36.56 | $0.00 |
DisclosureSEC source: 0001225208-11-013366 · doc4.xml · derivative · entry 4 KIM PETER S · CIK 0001181180 · Exe V-P & Pres, MRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,881 Underlying: Common Stock · 223,881 shares Expires 2021-05-03 F4 · derivative.exercise_date: The option vests in three equal annual installments beginning May 4, 2012. Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:43 UTC |
KIM PETER SExe V-P & Pres, MRL
|
GrantRestricted Stock Unit · Derivative | 16,411 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-013366 · doc4.xml · derivative · entry 3 KIM PETER S · CIK 0001181180 · Exe V-P & Pres, MRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,411 Underlying: Common Stock · 16,411 shares Expires 2014-05-04 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:43 UTC |
KOHAN RAUL EExe V-P & Pres, Animal Health
|
GrantStock Option (right to buy) · Derivative | 74,627 | $0.00 Strike: $36.56 | $0.00 |
DisclosureSEC source: 0001225208-11-013367 · doc4.xml · derivative · entry 4 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,627 Underlying: Common Stock · 74,627 shares Expires 2021-05-03 F3 · derivative.exercise_date: The option vests in three equal annual installments beginning May 4, 2012. Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:43 UTC |
KOHAN RAUL EExe V-P & Pres, Animal Health
|
GrantRestricted Stock Unit · Derivative | 5,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-013367 · doc4.xml · derivative · entry 3 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,470 Underlying: Common Stock · 5,470 shares Expires 2014-05-04 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:43 UTC |
Scalet J ChrisExe V-P Global Srvs & CIO
|
GrantStock Option (right to buy) · Derivative | 74,627 | $0.00 Strike: $36.56 | $0.00 |
DisclosureSEC source: 0001225208-11-013368 · doc4.xml · derivative · entry 4 Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,627 Underlying: Common Stock · 74,627 shares Expires 2021-05-03 F4 · derivative.exercise_date: The option vests in three equal annual installments beginning May 4, 2012. Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:43 UTC |
Scalet J ChrisExe V-P Global Srvs & CIO
|
GrantRestricted Stock Unit · Derivative | 5,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-013368 · doc4.xml · derivative · entry 3 Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,470 Underlying: Common Stock · 5,470 shares Expires 2014-05-04 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:44 UTC |
Rosenblatt MichaelExec V-P & Chief Med Officer
|
GrantStock Option (right to buy) · Derivative | 55,970 | $0.00 Strike: $36.56 | $0.00 |
DisclosureSEC source: 0001225208-11-013370 · doc4.xml · derivative · entry 2 Rosenblatt Michael · CIK 0001478797 · Exec V-P & Chief Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,970 Underlying: Common Stock · 55,970 shares Expires 2021-05-03 F2 · derivative.exercise_date: The option vests in three equal annual installments beginning May 4, 2012. Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:44 UTC |
Rosenblatt MichaelExec V-P & Chief Med Officer
|
GrantRestricted Stock Unit · Derivative | 4,103 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-013370 · doc4.xml · derivative · entry 1 Rosenblatt Michael · CIK 0001478797 · Exec V-P & Chief Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,103 Underlying: Common Stock · 4,103 shares Expires 2014-05-04 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:44 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
GrantStock Option (right to buy) · Derivative | 261,194 | $0.00 Strike: $36.56 | $0.00 |
DisclosureSEC source: 0001225208-11-013371 · doc4.xml · derivative · entry 4 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,194 Underlying: Common Stock · 261,194 shares Expires 2021-05-03 F3 · derivative.exercise_date: The option vests in three equal annual installments beginning May 4, 2012. Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:44 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
GrantRestricted Stock Unit · Derivative | 19,147 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-013371 · doc4.xml · derivative · entry 3 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,147 Underlying: Common Stock · 19,147 shares Expires 2014-05-04 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:45 UTC |
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
|
GrantStock Option (right to buy) · Derivative | 37,313 | $0.00 Strike: $36.56 | $0.00 |
DisclosureSEC source: 0001225208-11-013372 · doc4.xml · derivative · entry 3 AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,313 Underlying: Common Stock · 37,313 shares Expires 2021-05-03 F3 · derivative.exercise_date: The option vests in three equal annual installments beginning May 4, 2012. Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:45 UTC |
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
|
GrantRestricted Stock Unit · Derivative | 4,103 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-013372 · doc4.xml · derivative · entry 2 AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,103 Underlying: Common Stock · 4,103 shares Expires 2014-05-04 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 01, 2011 Filed May 2, 2011 20:32 UTC |
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
|
Exercise / conversionRSU - Leader Shares · Derivative | 1,000 | $35.95 | $35,950.00 |
DisclosureSEC source: 0001225208-11-012747 · doc4.xml · derivative · entry 3 AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2011-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 01, 2011 Filed May 2, 2011 20:32 UTC |
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
|
Tax withholdingCommon Stock | 364 | $35.95 | $13,085.80 |
DisclosureSEC source: 0001225208-11-012747 · doc4.xml · nonDerivative · entry 2 AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,097.2606 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 01, 2011 Filed May 2, 2011 20:32 UTC |
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
|
Exercise / conversionCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-012747 · doc4.xml · nonDerivative · entry 1 AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,461.2606 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 31, 2011 Filed Apr 1, 2011 12:58 UTC |
BRUN LESLIE ADirector
|
GrantPhantom Stock · Derivative | 473.3414 | $33.01 | $15,625.00 |
DisclosureSEC source: 0001225208-11-010578 · doc4.xml · derivative · entry 2 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,676.8374 Underlying: Common Stock · 473.3414 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 31, 2011 Filed Apr 1, 2011 12:58 UTC |
GLOCER THOMAS HDirector
|
GrantPhantom Stock · Derivative | 757.3463 | $33.01 | $25,000.00 |
DisclosureSEC source: 0001225208-11-010579 · doc4.xml · derivative · entry 2 GLOCER THOMAS H · CIK 0001140799 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,203.3603 Underlying: Common Stock · 757.3463 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 31, 2011 Filed Apr 1, 2011 12:59 UTC |
HARRISON WILLIAM B JRDirector
|
GrantPhantom Stock · Derivative | 1,098.1521 | $33.01 | $36,250.00 |
DisclosureSEC source: 0001225208-11-010580 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,257.7751 Underlying: Common Stock · 1,098.1521 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 31, 2011 Filed Apr 1, 2011 12:59 UTC |
KELLEY WILLAM NDirector
|
GrantPhantom Stock · Derivative | 870.9482 | $33.01 | $28,750.00 |
DisclosureSEC source: 0001225208-11-010581 · doc4.xml · derivative · entry 3 KELLEY WILLAM N · CIK 0001204361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,898.7312 Underlying: Common Stock · 870.9482 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 31, 2011 Filed Apr 1, 2011 12:59 UTC |
LAZARUS ROCHELLE BDirector
|
GrantPhantom Stock · Derivative | 757.3463 | $33.01 | $25,000.00 |
DisclosureSEC source: 0001225208-11-010582 · doc4.xml · derivative · entry 4 LAZARUS ROCHELLE B · CIK 0001082206 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,767.0493 Underlying: Common Stock · 757.3463 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 31, 2011 Filed Apr 1, 2011 13:00 UTC |
TATLOCK ANNE MDirector
|
GrantPhantom Stock · Derivative | 870.9482 | $33.01 | $28,750.00 |
DisclosureSEC source: 0001225208-11-010584 · doc4.xml · derivative · entry 3 TATLOCK ANNE M · CIK 0001020567 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,772.4522 Underlying: Common Stock · 870.9482 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 31, 2011 Filed Apr 1, 2011 12:59 UTC |
REPRESAS CARLOS EDirector
|
GrantPhantom Stock · Derivative | 833.0809 | $33.01 | $27,500.00 |
DisclosureSEC source: 0001225208-11-010583 · doc4.xml · derivative · entry 3 REPRESAS CARLOS E · CIK 0001216083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,267.7529 Underlying: Common Stock · 833.0809 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 31, 2011 Filed Apr 1, 2011 13:00 UTC |
WEEKS WENDELL PDirector
|
GrantPhantom Stock · Derivative | 833.0809 | $33.01 | $27,500.00 |
DisclosureSEC source: 0001225208-11-010585 · doc4.xml · derivative · entry 3 WEEKS WENDELL P · CIK 0001206158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,654.4859 Underlying: Common Stock · 833.0809 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 31, 2011 Filed Apr 1, 2011 13:00 UTC |
Wendell Peter CDirector
|
GrantPhantom Stock · Derivative | 757.3463 | $33.01 | $25,000.00 |
DisclosureSEC source: 0001225208-11-010586 · doc4.xml · derivative · entry 2 WENDELL PETER C · CIK 0001032635 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,235.0303 Underlying: Common Stock · 757.3463 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 28, 2011 Filed Mar 1, 2011 20:07 UTC |
CLARK RICHARD TDirector · Chairman
|
Exercise / conversionRestricted Stock Unit · Derivative | 61,500 | $32.19 | $1,979,685.00 |
DisclosureSEC source: 0001225208-11-007800 · doc4.xml · derivative · entry 5 CLARK RICHARD T · CIK 0001181282 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 61,500 shares Expires 2011-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| February 28, 2011 Filed Mar 1, 2011 20:07 UTC |
CLARK RICHARD TDirector · Chairman
|
Tax withholdingCommon Stock | 24,305 | $32.19 | $782,377.95 |
DisclosureSEC source: 0001225208-11-007800 · doc4.xml · nonDerivative · entry 2 CLARK RICHARD T · CIK 0001181282 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,211 Read SEC document |
| February 28, 2011 Filed Mar 1, 2011 20:07 UTC |
CLARK RICHARD TDirector · Chairman
|
Exercise / conversionCommon Stock | 61,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-007800 · doc4.xml · nonDerivative · entry 1 CLARK RICHARD T · CIK 0001181282 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,516 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2011 Filed Mar 1, 2011 20:08 UTC |
Turner MervynChief Strategy Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 4,650 | $32.19 | $149,683.50 |
DisclosureSEC source: 0001225208-11-007802 · doc4.xml · derivative · entry 5 Turner Mervyn · CIK 0001475383 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,650 shares Expires 2011-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| February 28, 2011 Filed Mar 1, 2011 20:08 UTC |
Turner MervynChief Strategy Officer
|
Tax withholdingCommon Stock | 1,691 | $32.19 | $54,433.29 |
DisclosureSEC source: 0001225208-11-007802 · doc4.xml · nonDerivative · entry 2 Turner Mervyn · CIK 0001475383 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,423.7647 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 28, 2011 Filed Mar 1, 2011 20:08 UTC |
Turner MervynChief Strategy Officer
|
Exercise / conversionCommon Stock | 4,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-007802 · doc4.xml · nonDerivative · entry 1 Turner Mervyn · CIK 0001475383 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,114.7647 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2011 Filed Mar 1, 2011 20:08 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
Exercise / conversionRestricted Stock Unit · Derivative | 9,375 | $32.19 | $301,781.25 |
DisclosureSEC source: 0001225208-11-007804 · doc4.xml · derivative · entry 5 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,375 shares Expires 2011-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| February 28, 2011 Filed Mar 1, 2011 20:08 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
Tax withholdingCommon Stock | 2,955 | $32.19 | $95,121.45 |
DisclosureSEC source: 0001225208-11-007804 · doc4.xml · nonDerivative · entry 2 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,242.4877 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.